Barclays upgrades Vertex Pharmaceuticals to Overweight, raises PT to $606 from $414.

miércoles, 28 de enero de 2026, 10:05 am ET1 min de lectura
VRTX--

Barclays upgrades Vertex Pharmaceuticals to Overweight, raises PT to $606 from $414.

Barclays upgrades Vertex Pharmaceuticals to Overweight, raises PT to $606 from $414.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios